23andMe seeks FDA approval for reporting Bloom syndrome
[gdlr_text_align class=”justify”] There has been an ongoing battle between the direct-to-consumer genetic testing company, 23andme, and the FDA. The FDA has been skeptical about the potential misunderstandings that could be caused [...]